Detalhe da pesquisa
1.
Outcomes of younger patients with mantle-cell lymphoma experiencing late relapse (>24 months): the LATE-POD study.
Blood
; 2024 05 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38754055
2.
Lenalidomide plus rituximab for the initial treatment of frail older patients with DLBCL: the FIL_ReRi phase 2 study.
Blood
; 142(17): 1438-1447, 2023 10 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37418685
3.
Real-life study on the use of response adapted therapy in patients with Hodgkin Lymphoma: Results from a multicenter experience.
Hematol Oncol
; 42(3): e3273, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38661120
4.
Biological features and outcome of diffuse large B-cell lymphoma associated with hepatitis C virus in elderly patients: Results of the prospective 'Elderly Project' by the Fondazione Italiana Linfomi.
Br J Haematol
; 201(4): 653-662, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36733229
5.
Real-world experience among patients with relapsed/refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor failure in Europe: The SCHOLAR-2 retrospective chart review study.
Br J Haematol
; 202(4): 749-759, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36257914
6.
Diffuse large B-cell lymphoma in octogenarians aged 85 and older can benefit from treatment with curative intent: a report on 129 patients prospectively registered in the Elderly Project of the Fondazione Italiana Linfomi (FIL).
Haematologica
; 108(4): 1083-1091, 2023 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36384247
7.
The elderly prognostic index predicts early mortality in older patients with diffuse large B-cell lymphoma. An ad hoc analysis of the elderly project by the Fondazione Italiana Linfomi.
Hematol Oncol
; 41(1): 78-87, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36177902
8.
Brentuximab vedotin consolidation after autologous stem cell transplantation for Hodgkin lymphoma: A Fondazione Italiana Linfomi real-life experience.
Hematol Oncol
; 40(1): 31-39, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34694649
9.
Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in elderly HL: a two-center experience in 123 patients.
Ann Hematol
; 99(6): 1321-1330, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32333153
10.
Feasibility of all-oral anti-HCV treatment during DHAP chemotherapy and autologous stem cell transplantation for T-cell lymphoma.
New Microbiol
; 41(3): 242-245, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29620791
11.
The use of anthracycline at first-line compared to alkylating agents or nucleoside analogs improves the outcome of salvage treatments after relapse in follicular lymphoma The REFOLL study by the Fondazione Italiana Linfomi.
Am J Hematol
; 90(1): 56-61, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25327841
12.
Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death.
Br J Haematol
; 185(5): 940-944, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30407625
13.
Indirect treatment comparison of brexucabtagene autoleucel (ZUMA-2) versus standard of care (SCHOLAR-2) in relapsed/refractory mantle cell lymphoma.
Leuk Lymphoma
; 65(1): 14-25, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37840282
14.
Current Treatment Options and the Role of Functional Status Assessment in Classical Hodgkin Lymphoma in Older Adults: A Review.
Cancers (Basel)
; 15(5)2023 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36900306
15.
Parsaclisib, a PI3Kδ inhibitor, in relapsed and refractory mantle cell lymphoma (CITADEL-205): a phase 2 study.
EClinicalMedicine
; 62: 102131, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37599908
16.
Long-term follow-up of rituximab plus bendamustine and cytarabine in older patients with newly diagnosed MCL.
Blood Adv
; 7(15): 3916-3924, 2023 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37171620
17.
Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the Fondazione Italiana Linfomi MCL0208 trial.
Blood Adv
; 7(14): 3764-3774, 2023 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37058477
18.
A Fondazione Italiana Linfomi cohort study of R-COMP vs R-CHOP in older patients with diffuse large B-cell lymphoma.
Blood Adv
; 7(15): 4160-4169, 2023 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37276080
19.
Romidepsin-CHOEP followed by high-dose chemotherapy and stem-cell transplantation in untreated Peripheral T-Cell Lymphoma: results of the PTCL13 phase Ib/II study.
Leukemia
; 37(2): 433-440, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36653509
20.
HBV Reactivation in Patients with Past Infection Affected by Non-Hodgkin Lymphoma and Treated with Anti-CD20 Antibody Based Immuno-Chemotherapy: A Multicenter Experience.
J Pers Med
; 12(2)2022 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35207774